John Palcza

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

Matthew Kennedy, Andrew W. Stamford, Xia Chen et al. · Science Translational Medicine · 2016 · 407 citations

Glucose Homeostasis, Bace1 Inhibitor Verubecestat, Enzyme 1 +20

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

Xavier Forns, Stuart C. Gordon, Eli Zuckerman et al. · Journal of Hepatology · 2015 · 140 citations

Viral Hepatitis, Antiviral Therapy, Hepatitis +7

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE: Table 1.

Stuart C. Gordon, Eli Zuckerman, Eric Lawitz et al. · Clinical Infectious Diseases · 2015 · 90 citations · Full text

Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974)

Simon Sinclair, Stefanie A. Kane, Bart Van der Schueren et al. · British Journal of Clinical Pharmacology · 2009 · 85 citations · Full text

Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea

Hong Sun, John Palcza, Deborah Card et al. · Journal of Clinical Sleep Medicine · 2016 · 76 citations · Full text